JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB7149

Goat Anti-Human IgG H&L (FITC) preadsorbed

Goat Anti-Human IgG H&L (FITC) preadsorbed

Be the first to review this product! Submit a review

|

(4 Publications)

Suitable for Flow Cyt, IHC-Fr, IHC-P, IM, ELISA, ICC/IF. Preadsorbed to minimise non-specific binding and high background staining. Cited in 4 publications.

別名を表示する

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

Key facts

宿主種

Goat

ターゲット種

Human

ターゲットアイソタイプ

IgG

ターゲット特異性

Heavy & Light chains

最小限の交差反応性

Mouse, Rat, Sheep, Rabbit, Goat, Horse, Chicken, Guinea pig, Hamster, Cow,

血清吸着処理済み

Yes

標識

FITC

励起波長/蛍光波長

Ex: 495nm, Em: 519nm

アプリケーション

ICC/IF, IHC-Fr, ELISA, Flow Cyt, IM, IHC-P

applications

クローン性

Polyclonal

特異性

No reaction was observed against Bovine, Chicken, Goat, Guinea Pig, Hamster, Horse, Mouse, Rabbit, Rat and Sheep Serum Proteins.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "Flow Cyt": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "IHC-Fr": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "IM": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/10000 - 1/50000", "notes":"<p></p>" }, "ICC/IF": { "reactivity":"NO_EXPERIMENTAL_DATA_EXPECTED_TO_REACT", "dilution-info":"1/1000 - 1/5000", "notes":"<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
精製に関する特記事項
Secondary Antibodies are prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities.
バッファー組成
Preservative: 0.01% Sodium azide Constituents: 1% BSA, 0.88% Sodium chloride, 0.424% Potassium phosphate solution
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
+4°C

製品プロトコール

ターゲットの情報

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

追加のターゲット

IGHG4,IGHG3,IGHG2

文献 (4)

Recent publications for all applications. Explore the full list and refine your search

Journal of food and drug analysis 33:172-178 PubMed40592335

2025

Yiqi Yangyin Tongluo prescription targets lncRNA VIM-AS1 to regulate FOXK2/mTOR to promote autophagy and inhibit renal tubular epithelial cell apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Rucui Yu,Ruiying Wu,Tingting Chen,Jingwei Xu

Marine life science & technology 7:328-339 PubMed40417257

2025

A novel anti-OX40 human monoclonal antibody that blocks OX40/OX40L signaling and depletes OX40 T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zhen Li,Lin Liu,Xiaobo Chen,Yanqing Wang,Yuxuan Wang,Yuxiu Zhang,Bingqiang Zhang,Xiao Wu,Muhammad Omer Iqbal,Jin Chen,Yuchao Gu

Journal of neuroinflammation 18:53 PubMed33612107

2021

Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit.

Applications

Unspecified application

Species

Unspecified reactive species

Yuewen Ding,Zheye Zhou,Jinyu Chen,Yu Peng,Haitao Wang,Wei Qiu,Wei Xie,Jun Zhang,Honghao Wang

Pharmaceuticals (Basel, Switzerland) 13: PubMed33316945

2020

Stem Cell-Derived Exosomes Ameliorate Doxorubicin-Induced Muscle Toxicity through Counteracting Pyroptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Fatima Bianca A Dessouki,Rakesh C Kukreja,Dinender K Singla
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com